You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Clinical characteristics of 95 NSCLC patients with bone metastases

From: Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy

Characteristic Whole group Only bone metastases Bone with other organ metastases
   Metastases to 1–2 sites Metastases to ≥2sites  
Gender     
Male 68 18 18 32
Female 27 2 9 16
Age (years)     
Range (median) 30 ~ 78(59) 40 ~ 78(62) 41 ~ 72(59) 30 ~ 76(58)
<60 50 9 14 27
≥60 45 11 13 21
Pathological type     
Squamous 31 7 10 14
Non-squamous 64 13 17 34
T stage     
T1–2 36 11 10 15
T3–4 59 9 17 33
N stage     
N0–1 14 3 4 7
N2–3 81 17 23 41
GTV 95 17 ~ 489(142) 28 ~ 604(147) 28 ~ 628(179)
KPS     
70 39 5 9 25
>70 56 15 18 23
Prescribed dose     
Range (median) 9 ~ 76(63) 23 ~ 76(63) 9 ~ 72(63) 9 ~ 68(58)
<63 Gy 47 10 8 29
≥63 Gy 48 10 19 19
Treatment response of primary tumor     
CR + PR 66 15 18 33
SD + PD 29 5 9 15
Chemotherapy     
Range (median) 2 ~ 5(4) 2 ~ 4(3) 2 ~ 4(4) 2 ~ 5(4)
2-3 cycles 43 10 9 24
≥4 cycles 52 10 18 24
Radiation to metastases     
Yes 15 9 3 3
No 80 11 24 45
  1. Note: GTV from a minimum ~ maximal value cm3 (median).